Table of Contents
Overview
Definition of Dementia
Dementia is an umbrella term that encompasses a variety of neurological conditions that progressively impair cognitive functions, including memory, reasoning, and the ability to perform daily activities. It is characterized by a decline in cognitive abilities to the extent that it interferes with an individual's daily life and activities, often accompanied by changes in mood, behavior, and personality.[2.1] Dementia is a general term that encompasses a range of cognitive impairments, with Alzheimer's disease being the most prevalent form, accounting for a significant proportion of dementia cases.[3.1] The two most common types of dementia are Alzheimer's and vascular dementia, which share some symptoms but have key differences in their underlying causes and treatment approaches.[20.1] Vascular dementia is the second most common type and typically affects individuals aged 55 to 70, representing approximately 10-20 percent of all dementia cases, many of which remain undiagnosed.[19.1] Understanding these distinctions is crucial for effective diagnosis and management of dementia. Globally, dementia poses a significant public health challenge, with approximately 47 million people affected, a number projected to rise to 131 million by 2050.[4.1] The complexity of dementia is underscored by the fact that over 70 different causes have been identified, complicating diagnosis and treatment strategies.[17.1] Understanding the various types of dementia and their specific characteristics is crucial for effective management and care.[20.1]Common Signs and Symptoms
Dementia is characterized by a range of emotional and behavioral changes that can significantly impact relationships with family members. One notable change is the diminished emotional response, which can lead to profound effects on familial interactions. For instance, a person with dementia may fail to react to humorous situations as they once did, resulting in feelings of disconnect for family members who are accustomed to shared laughter and joy.[8.1] Additionally, individuals with dementia may experience fluctuations in their emotional states, including irritability and rapid mood changes. These emotional disturbances can manifest as overreactions to minor issues or a general sense of distance and disinterest in activities that were previously enjoyable.[10.1] Such changes can create tension within family dynamics, as caregivers may struggle with feelings of frustration or anger, which can further exacerbate conflicts and hurt feelings among family members.[9.1] To mitigate these challenges, families can adopt various strategies to maintain connections despite the emotional changes associated with dementia. Engaging in non-verbal forms of communication, such as shared activities or physical touch, can help bridge the emotional gap and foster a sense of closeness.[8.1] Moreover, caregivers are encouraged to find healthy outlets for their own stress and anger, such as exercise or therapy, to protect their emotional well-being and, by extension, the health of family relationships.[9.1]History
Historical Concepts of Dementia
The concept of dementia has evolved significantly over centuries, with its roots traceable to ancient civilizations. The term "dementia" itself derives from the Latin root demens, meaning "out of one's mind," and while it has been in use since the 13th century, its medical application emerged in the 18th century.[57.1] Historical texts, including references from the Old Testament, indicate that dementia-like conditions were recognized long before modern understandings of the disease.[51.1] In the 19th century, the understanding of dementia evolved significantly as individuals with this condition were increasingly recognized as patients deserving of medical care from specialists known as alienists. During this period, senile dementia was classified as a medical disease, reflecting a shift in societal attitudes towards mental health.[52.1] The term "dementia" began its medical usage in this century, influenced by the contributions of French neurologists such as Philippe Pinel and Jean Esquirol, who played a crucial role in the broader understanding of mental illnesses.[52.1] It is important to note that the history of dementia did not begin with the work of Alzheimer and his colleagues; rather, it encompasses earlier figures like Pinel, who, while significant, did not invent the term "dementia" itself.[56.1] This historical context highlights the evolution of the concept of dementia prior to the advancements made by later researchers.[56.1] The early 20th century marked a pivotal moment in the history of dementia, particularly with the contributions of Alois Alzheimer and Emil Kraepelin. In 1906, Alzheimer described the first case of what would later be known as Alzheimer's disease, although the understanding of dementia prior to this was already rich, with references dating back to ancient Greek and Roman thought.[54.1] Kraepelin's work further advanced the field; in 1910, he formally categorized Alzheimer's disease in his influential textbook, distinguishing it from other forms of dementia and establishing criteria that would influence modern diagnostic practices.[65.1] Throughout these historical developments, societal perceptions of dementia have also evolved. Initially, dementia was thought to predominantly affect White men, but contemporary research indicates a higher prevalence among women and within African American and Hispanic communities.[66.1] This shift in understanding reflects broader changes in societal attitudes towards mental health and the recognition of dementia as a complex condition influenced by various demographic factors.Milestones in Alzheimer's Disease Research
In March 2023, the Alzheimer's Association International Conference (AAIC) convened to discuss significant advancements in Alzheimer's disease research, particularly focusing on the immune system's role in Alzheimer's disease and related dementias (ADRD). The conference covered various topics, including animal models that replicate human pathology, immune-related biomarkers, and clinical trials, highlighting the ongoing efforts to understand and combat the disease.[71.1] In the realm of clinical trials, the National Institutes of Health (NIH) has played a crucial role by funding foundational research that has led to pivotal phase 3 clinical trials for Alzheimer's treatments. Although NIH did not fund the trials that resulted in FDA approvals, it supported essential research that elucidated the role of amyloid proteins and developed amyloid PET imaging technology, which is central to these trials. In fall 2023, NIH began funding the Alzheimer’s Disease Tau Platform Clinical Trial, aimed at testing tau-targeting therapies in conjunction with amyloid-reducing drugs for patients with early Alzheimer's.[72.1] The year 2023 marked a significant milestone with the U.S. FDA approving several drugs for Alzheimer's disease, a notable increase from the previous year when no approvals were granted. Among these, the anti-amyloid antibody Leqembi (lecanemab) received traditional approval as the first disease-modifying therapy for Alzheimer's, representing a breakthrough in treatment options.[74.1] Another anti-amyloid treatment was also approved in 2023, further contributing to the arsenal of therapies available to slow disease progression in individuals exhibiting cognitive decline.[75.1] Research at Yale School of Medicine has introduced new hypotheses regarding axonal spheroids, a byproduct of amyloid plaques that may play a significant role in Alzheimer's pathology. This research aims to reverse the growth of these spheroids, which impede neuronal communication, thereby offering potential new avenues for treatment.[73.1] Advocacy efforts have also significantly influenced Alzheimer's research funding and priorities. The Alzheimer's Impact Movement (AIM), as the advocacy arm of the Alzheimer's Association, has successfully tripled research funding over five years, demonstrating the power of public awareness and advocacy in shaping research agendas.[76.1] AIM and its advocates continue to push for bipartisan legislation that positively impacts individuals living with Alzheimer's and their caregivers.[77.1] Understanding advocacy strategies is essential for improving dementia awareness, reducing stigma, and influencing policy to support those affected by the disease.[78.1] Alzheimer's Awareness Month serves as a vital platform for educating the public about the disease's impact, emphasizing the importance of early diagnosis and advancements in research.[80.1] Currently, NIH allocates approximately $3.8 billion annually for Alzheimer's and dementia research, enabling scientists to advance knowledge, explore risk reduction strategies, and uncover new biomarkers for early diagnosis and treatment.[81.1]Types Of Dementia
Primary Dementia
Dementia encompasses a range of cognitive impairments that interfere with daily activities, primarily due to the degeneration of neurons in the brain. Among the various types of dementia, four primary forms are recognized: Alzheimer's Disease, Frontotemporal Dementia, Lewy Body Dementia, and Vascular Dementia. Each type exhibits distinct characteristics, symptoms, and typical ages of diagnosis. Alzheimer's Disease is the most prevalent form of dementia, often beginning with memory issues and progressing to more severe cognitive decline. It is characterized by the formation of amyloid plaques and tau tangles in the brain, leading to significant impairments in memory, reasoning, and behavior.[100.1] The typical age of diagnosis for Alzheimer's is in the mid-60s, although some cases can occur earlier.[98.1] Frontotemporal Dementia (FTD) typically affects individuals between the ages of 45 and 64. This type is marked by changes in personality and behavior, as well as difficulties with language and executive functions. Unlike Alzheimer's, FTD often presents with more pronounced behavioral changes early in the disease process.[98.1] Lewy Body Dementia (DLB) is one of several types of dementia, which also include Alzheimer’s Disease, Frontotemporal Dementia, and Vascular Dementia.[96.1] This condition is characterized by the presence of abnormal protein deposits in the brain, leading to a variety of symptoms. Individuals with Lewy Body Dementia may experience cognitive decline, including difficulties with concentration and attention, as well as visual hallucinations and movement problems such as muscle rigidity and loss of coordination.[96.1] The typical age of diagnosis for DLB is 50 years and older, with some cases presenting in individuals as young as their mid-30s to 60s.[96.1] Diagnosing DLB can be particularly challenging, as symptoms often overlap with those of other types of dementia, and some individuals may have more than one form of dementia simultaneously, complicating the diagnostic process.[96.1] Dementia is a brain condition that results in difficulties with thinking, behavior, and memory, often stemming from various health issues, such as strokes.[99.1] Among the various types of dementia, Alzheimer's disease is recognized as the most prevalent form.[100.1] While Alzheimer's typically begins with memory-related problems, vascular dementia may present initially with challenges in planning, organizing, and decision-making.[99.1] It is also important to note that individuals can experience multiple types of dementia simultaneously; for instance, a person may have both Alzheimer's disease and vascular dementia.[100.1] Understanding these distinctions is essential for accurate diagnosis and effective management of dementia-related conditions. It is important to note that symptoms can overlap among these types of dementia, and individuals may experience more than one form simultaneously, complicating accurate diagnosis.[98.1] Understanding these primary types of dementia is crucial for developing effective treatment strategies and providing appropriate care for affected individuals.In this section:
Diagnosis And Assessment
Diagnostic Criteria
The diagnostic criteria for dementia involve a comprehensive and multifaceted approach to accurately identify the condition and its underlying causes. This process is essential as it allows healthcare professionals to tailor management strategies effectively to the individual's needs. A timely, personalized, and accurate diagnosis is crucial, as certain interventions are only suitable for specific dementia subtypes, and the implications of a diagnosis can vary significantly between these subtypes.[156.1] Dementia is a significant global health concern, currently affecting approximately 47 million individuals worldwide, with projections indicating that this number could rise to 131 million by 2050.[141.1] In the United States, the prevalence of dementia is particularly notable among older adults, with about 15% of individuals over the age of 68 affected.[142.1] Alzheimer's disease, which is the most common form of dementia, currently impacts 5.8 million people in the U.S..[143.1] Furthermore, it is projected that by 2050, the number of individuals affected by Alzheimer's disease could increase to 13.8 million.[142.1] The diagnostic process for dementia typically includes a thorough evaluation of the individual's health and cognitive status, integrating both traditional and advanced diagnostic methods. This comprehensive assessment is designed to ensure a more accurate diagnosis and to facilitate the development of effective treatment plans.[157.1] Despite the critical need for early diagnosis, dementia remains one of the most misunderstood conditions affecting older adults, leading to significant misconceptions that can deter individuals from seeking timely medical advice. One prevalent myth is that memory loss is the sole indicator of dementia; however, while memory issues are a defining symptom, dementia encompasses a broader range of cognitive impairments that affect daily functioning and is not limited to occasional lapses in memory.[160.1] Furthermore, it is essential to recognize dementia as a disease rather than an expected part of aging, as this understanding is crucial for promoting early diagnosis and intervention.[159.1] Addressing these misconceptions is vital to reduce stigma and encourage individuals to pursue appropriate diagnostic and treatment options.[158.1]Tools and Techniques for Diagnosis
Diagnosing dementia involves a multifaceted approach that utilizes various tools and techniques to assess cognitive function and identify specific types of dementia. There is no single test for dementia; instead, a combination of methods is employed to arrive at a diagnosis. These methods include neuropsychological testing, which is crucial for documenting cognitive deficits that are key criteria for diagnosis. Tests that assess memory impairment are particularly significant, as Alzheimer's disease, the most common form of dementia, primarily affects memory.[161.1] Recent advancements in diagnostic tools for dementia have become a significant focus in public health policy, particularly due to the increasing prevalence of the disease. Among these advancements, structural brain imaging and molecular techniques have shown promise in enhancing the accuracy of dementia diagnoses, as they contribute to a better understanding of clinical phenotypes, neuropathology, and pathophysiological mechanisms.[155.1] Additionally, machine learning (ML) algorithms have been employed in various studies, demonstrating their effectiveness in early detection and screening of dementia. A total of 12 different ML algorithms, including support vector machines and deep neural networks, have yielded promising results in this area.[151.1] Notably, one proposed model achieved an impressive 99.68% accuracy in distinguishing between the four stages of Alzheimer's disease, underscoring its potential for real-time analysis and early diagnosis.[153.1] These tools collectively represent a significant advancement in the diagnostic landscape for dementia, offering healthcare professionals valuable resources for improving patient outcomes. Blood tests may also be considered in the diagnostic process, although they should not be used in isolation. Instead, they are typically evaluated alongside other tests to provide a more comprehensive view of the individual's cognitive health.[145.1] Emerging technologies, such as the Eye-AD deep learning framework, leverage optical coherence tomography angiography (OCTA) images to detect early-onset Alzheimer's disease and mild cognitive impairment, showcasing the potential of innovative imaging techniques in dementia diagnosis.[154.1]In this section:
Recent Advancements
New Drug Therapies
Recent advancements in dementia research and clinical care have continued to accelerate in 2024. Monoclonal antibody anti-amyloid immunotherapies (AATs) have been approved for clinical use for patients with mild cognitive impairment or early dementia due to Alzheimer's disease in multiple countries and regions, including China, Hong Kong, Israel, Japan, Korea, the European Union, the United Arab Emirates, and the United States.[190.1] These developments signify a crucial step forward in the treatment strategies for Alzheimer's disease, focusing on the underlying amyloid pathology associated with the condition.[190.1] The National Institutes of Health (NIH) has played a crucial role in supporting foundational research that led to these advancements. Although NIH did not fund the pivotal phase 3 clinical trials for these therapies, its funding facilitated essential preliminary studies that enhanced the understanding of amyloid's role in Alzheimer's and the development of amyloid PET imaging technology, which is vital for these trials.[192.1] Furthermore, NIH is currently funding the Alzheimer’s Disease Tau Platform Clinical Trial, which aims to evaluate tau-targeting therapies in conjunction with amyloid-reducing drugs.[192.1] In addition to monoclonal antibodies, innovative treatments are emerging from preclinical studies. For instance, researchers at Penn Medicine have identified a molecular compound that mimics natural chaperones, which are often depleted in the aging brain. This compound has shown promise in reversing signs of Alzheimer's disease in mouse models, improving memory performance and restoring normal protein regulation processes.[193.1] Such findings underscore the potential for new therapeutic approaches that address the underlying mechanisms of the disease. Despite these advancements, the approval process for monoclonal antibody therapies has faced challenges. The accelerated approval pathway, while allowing for quicker access to treatments, requires sponsors to conduct post-market clinical trials to confirm efficacy, which can extend the timeline for broader patient access.[209.1] The controversy surrounding the approval of drugs like aducanumab highlights the ongoing debates regarding clinical efficacy and the implications for patient care.[210.1]Non-Pharmacological Approaches
Non-pharmacological approaches to dementia care have gained recognition for their effectiveness in enhancing the quality of life for individuals living with dementia. These strategies focus on cognitive stimulation, emotional support, and social interaction, which are crucial for maintaining cognitive function and emotional well-being. Cognitive stimulation has been associated with improved cognitive function and enhanced quality of life for people with dementia. Engaging in activities that promote cognitive engagement can lead to better communication and social interactions, thereby fostering a more supportive environment for individuals with dementia.[214.1] Cognitive training, which originated in the 1970s for stroke and head trauma victims, has also been adapted for dementia patients. This therapy involves practicing standardized tasks aimed at improving specific cognitive skills.[215.1] Social interaction is another vital component of non-pharmacological interventions. Programs that encourage participation in semi-structured, peer-to-peer group activities have shown to engage both cognitive and social functions, increasing the likelihood of meaningful engagement among participants.[216.1] Furthermore, music therapy has emerged as a beneficial intervention, with studies indicating that regular sessions can reduce behavioral and psychological symptoms of dementia, such as agitation and depression.[217.1] Validation therapy is another effective psychosocial treatment that addresses the emotional needs of dementia patients. This approach acknowledges and validates the feelings of individuals with dementia, helping to alleviate the negative emotions that may be trapped within them.[218.1]In this section:
Risk Factors And Prevention
Controllable and Uncontrollable Risk Factors
Dementia risk factors can be categorized into controllable and uncontrollable factors, each playing a significant role in the likelihood of developing the condition. Uncontrollable risk factors for dementia primarily include age and genetic predispositions. Age is a significant risk factor, as the likelihood of developing dementia increases with advancing age. Recent research has identified over 70 genetic regions associated with Alzheimer’s disease, highlighting the complexity of genetic influences on dementia risk.[237.1] Among these, several genetic variants have been found to either increase or decrease an individual's risk of developing Alzheimer’s.[235.1] Notably, the APOE ε2 variant has been identified as providing some protection against the disease, while other mutations in genes such as APP, PSEN1, and PSEN2 are linked to early-onset Alzheimer’s disease (EOAD) and contribute to the amyloid hypothesis, which posits that amyloid accumulation plays a critical role in Alzheimer’s pathology.[236.1] Furthermore, individuals with Down syndrome, who possess an extra copy of chromosome 21 carrying the APP gene, are at a higher risk for developing early-onset Alzheimer’s.[235.1] This growing body of research underscores the importance of understanding genetic markers in predicting Alzheimer’s risk and developing targeted prevention strategies.[234.1] Controllable risk factors for dementia include various lifestyle choices and health conditions that can be modified to potentially reduce the risk of developing the disease. Key factors include managing chronic health conditions such as diabetes and adopting healthy lifestyle habits, which can lower the risk of dementia, including Alzheimer's disease.[227.1] The 2024 update to the Lancet Commission on dementia prevention has identified additional modifiable risk factors, such as high LDL cholesterol and vision loss, indicating that nearly half of all dementia cases worldwide could be prevented or delayed by addressing these 14 modifiable risk factors.[225.1] Furthermore, factors such as age, genetics, smoking, alcohol consumption, and cholesterol levels also play a significant role in influencing dementia risk.[226.1] Understanding these factors is crucial for effective prevention and intervention strategies.[224.1]Lifestyle Changes to Reduce Risk
Making healthy lifestyle choices is crucial in reducing the risk of dementia. Engaging in moderate physical activity is one of the most effective strategies, as it has been shown to decrease the risk of cognitive decline and dementia.[239.1] Additionally, maintaining psychological well-being, such as avoiding depression, and fostering regular social engagement are important lifestyle factors that contribute to cognitive health.[239.1] Dietary choices also play a significant role in dementia prevention. The Mediterranean diet, characterized by high consumption of fruits, vegetables, whole grains, and healthy fats, particularly olive oil, has been associated with a decreased risk of cognitive decline.[231.1] Foods rich in omega-3 fatty acids, such as fatty fish, are particularly beneficial, as they have been linked to improved memory and a lower likelihood of developing dementia.[233.1] Furthermore, managing vascular health is essential, as conditions like high blood pressure and diabetes can increase the risk of dementia.[229.1] Therefore, controlling these vascular risk factors through lifestyle changes, such as regular exercise and a balanced diet, is recommended.[238.1] Engagement in cognitively stimulating activities is associated with a reduced risk of cognitive decline and the onset of dementia, suggesting that behavioral and lifestyle choices may influence age-related cognitive changes and serve as potential targets for strategies aimed at delaying or preventing dementia.[242.1] Additionally, making healthy lifestyle choices can help reduce the risk of developing dementia, although no single behavior is guaranteed to prevent it.[243.1] Evidence indicates that dementia risk is lowest among individuals who maintain healthy behaviors during mid-life, specifically between the ages of 40 and 65.[244.1] Therefore, incorporating regular physical activity, social connections, and cognitive engagement into daily routines may be beneficial in mitigating dementia risk.[243.1]Caregiving And Support
Resources for Caregivers
Caregivers of individuals with dementia have access to a variety of resources designed to support them in their challenging roles. These resources encompass educational materials, training programs, and community support initiatives. Educational resources play a crucial role in equipping caregivers with the knowledge necessary to understand dementia and its effects. For instance, programs that teach community members and caregivers about the signs and symptoms of dementia, including Alzheimer's disease, are vital. These programs also provide information on communication barriers and strategies to overcome them, as well as creative problem-solving techniques for common caregiving challenges.[269.1] Additionally, caregivers can benefit from understanding the broader implications of dementia, such as recognizing it as a disease rather than a normal part of aging, which is essential for promoting early diagnosis and intervention.[278.1] Training resources are equally important for caregivers. Dementia training programs offer essential knowledge and skills to effectively manage the challenges associated with caregiving. These programs can enhance caregivers' understanding of the disease, improve communication strategies, and develop practical caregiving techniques.[282.1] Furthermore, accessing free online training resources and webinars can help caregivers learn new strategies and identify symptoms of burnout early.[277.1] Community support is an essential resource for caregivers, as caregiving often involves multiple family members sharing responsibilities for individuals with dementia, including Alzheimer’s disease.[271.1] Many families in the United States engage in caregiving for friends or relatives with dementia, highlighting the collaborative nature of this role.[271.1] Support groups can provide valuable assistance to caregivers by offering a platform for sharing strategies and experiences, which can be beneficial for managing the challenges associated with caregiving.[271.1] These groups also emphasize the importance of mental and emotional self-care for caregivers, which is crucial for sustaining their well-being throughout the caregiving journey.[271.1] In addition to educational and community resources, caregivers are encouraged to implement self-care strategies. This includes establishing a self-care routine, seeking help from family and friends, and utilizing local services such as adult day care.[276.1] Recognizing the importance of self-care can significantly enhance caregivers' well-being and improve the quality of care they provide.[275.1]Support Systems for Individuals with Dementia
Support systems for individuals with dementia play a vital role in enhancing their quality of life and ensuring effective care. Alzheimer's disease is characterized by gradual memory loss, which is linked to specific brain changes such as amyloid plaques and tau tangles.[293.1] In addition to Alzheimer's, vascular dementia and Lewy body dementia are significant types of dementia, each presenting unique challenges that can influence caregiving strategies. For instance, Alzheimer's disease is primarily marked by memory loss, while vascular dementia may exhibit different symptoms that can complicate care approaches.[293.1] Understanding the distinctions between these types of dementia is essential for caregivers, as it allows them to adopt appropriate strategies tailored to the specific needs of individuals affected by each type.[293.1] Creating a structured environment is a fundamental aspect of caregiving for individuals with dementia. Establishing a consistent daily routine can significantly reduce stress for both the caregiver and the person with dementia. This routine should include predictable activities that provide stability and comfort, as well as enjoyable activities that the individual appreciates, such as listening to music or engaging in puzzles.[315.1] Incorporating these elements not only helps maintain the individual's quality of life but also draws on long-term memory, which tends to remain intact longer than short-term memory.[316.1] As dementia progresses, individuals will increasingly require assistance with daily tasks, including eating meals, taking medications, and attending to personal care needs such as bathing and dressing.[313.1] Establishing a consistent daily routine can provide stability and predictability for both the person with dementia and their caregiver, which is essential for reducing anxiety.[316.1] Incorporating enjoyable activities, such as listening to music, going for walks, or working on puzzles, can help maintain the quality of life for individuals with dementia.[314.1] It is important to recognize that every person with dementia and their caregiver is unique, and thus, routines should be tailored to meet their specific needs.[317.1] Caregivers must also prioritize their own well-being to sustain the energy and emotional resilience necessary for effective caregiving.[314.1]Future Directions
Ongoing Research and Clinical Trials
Ongoing research in dementia is increasingly focused on addressing significant gaps in understanding the disease and improving treatment strategies. The National Institutes of Health (NIH) has made substantial investments in research aimed at identifying early signs of Alzheimer's and related dementias, developing effective interventions, and enhancing care for individuals living with dementia and their caregivers. This includes advancements in drug development, behavioral and lifestyle interventions, cognitive assessments, and the exploration of dementia risk and protective factors.[320.1] A critical area of ongoing research involves the integration of technology in dementia care. The Internet of Things (IoT) is being utilized for early detection through in-home sensors and wearable monitoring, which can facilitate better healthcare management for patients.[318.1] Furthermore, future directions in dementia therapy may incorporate nanotechnology for brain repair or drug delivery, indicating a shift towards innovative treatment modalities.[318.1] Research is also focusing on geographical and demographic disparities in dementia care. Studies have highlighted that certain racial and ethnic groups are less likely to receive timely and accurate diagnoses or appropriate medications compared to non-Hispanic white Americans.[341.1] Addressing these disparities is essential, as health system changes that improve access to disease-modifying treatments could enhance health equity and the overall impact of dementia care.[342.1] Moreover, the International Research Network on Dementia Prevention has identified priorities for future research, emphasizing the need for more representative studies that consider diverse populations and the mechanisms underlying dementia.[319.1] This is particularly important as the older population in the United States becomes increasingly diverse, necessitating a better understanding of cultural views and interpretations of dementia that may influence care.[363.1] To foster the development of dementia-friendly communities, several key strategies have been identified. These include (a) the active involvement of people with dementia and their informal caregivers, (b) inclusive environmental design, (c) public education aimed at reducing stigma and raising awareness, and (d) customized strategies informed by dementia-friendly and inclusive theories.[360.1] This scoping review provides an overview of current evidence on these strategies, emphasizing their role in supporting social inclusion for individuals living with dementia.[361.1]Emerging Technologies in Dementia Care
Recent advancements in dementia care have accelerated significantly in 2024, particularly with the approval of monoclonal antibody anti-amyloid immunotherapies (AATs) for clinical use in patients with mild cognitive impairment or early dementia due to Alzheimer's disease across various countries and regions, including China, Hong Kong, Israel, Japan, Korea, the EU, the United Arab Emirates, and the USA.[321.1] Dementia not only affects the diagnosed individuals but also has profound implications for the psychological and emotional well-being of their families.[322.1] Consequently, it is essential to provide holistic support and care to the entire family, as psychosocial interventions have been shown to significantly impact families living with dementia.[322.1] Furthermore, epidemiological predictions indicate that the prevalence of dementia will continue to rise, leading to significant social and economic ramifications, which underscores the need for effective interventions that extend beyond pharmacological management.[323.1] Emerging technologies in dementia care increasingly emphasize the role of psychosocial interventions, which include strategies such as occupational and behavioral therapy. These interventions have been shown to effectively support individuals with dementia and their caregivers in adapting to the cognitive and behavioral changes they encounter in daily life.[326.1] Despite their demonstrated benefits, psychosocial interventions have not yet been fully integrated into routine care, indicating a significant gap in their application.[325.1] It is essential to recognize that these interventions are designed not only for individuals diagnosed with dementia but also for their families, providing holistic support that enhances the overall quality of life.[322.1] The impact of psychosocial interventions on families living with dementia is profound, as they address the psychological and emotional well-being of both patients and their loved ones.[322.1] Looking towards the future, nanotechnology presents a promising avenue for revolutionizing dementia treatment. This technology could enable highly targeted therapies that may halt or even reverse the progression of Alzheimer's disease.[328.1] The unique properties of nanomaterials allow for enhanced detection and treatment capabilities, which could significantly improve early diagnosis and management of the disease.[333.1] However, further research and clinical trials are necessary to establish the safety and efficacy of these nanotechnology-based interventions.[332.1] In addition to nanotechnology, the role of IoT in dementia care is expanding. The integration of sophisticated sensors and AI algorithms can enhance monitoring systems, providing real-time data that can assist in the diagnosis and management of dementia.[335.1] A proposed model, "Demencare," exemplifies this approach by utilizing a network of sensors to relay patient information to caregivers, thereby improving personalized care.[336.1] Furthermore, AI has shown promise in aiding the early detection of dementia through the analysis of digital biomarkers, suggesting a future where technology plays a crucial role in identifying and managing the condition.[337.1]In this section:
References
[2] What is dementia? | Alzheimer's Society — Dementia describes a group of symptoms that include problems with memory, thinking or language, and changes in mood, emotions, perception and behaviour. The word 'dementia' describes a set of symptoms that over time can affect memory, problem-solving, language and behaviour. Alzheimer's disease is the most common type of dementia.
[3] What is Dementia? Symptoms, Causes & Treatment | alz.org — About Alzheimer's & Dementia About Alzheimer's & Dementia About Alzheimer's & Dementia About Alzheimer's & Dementia About Alzheimer's & Dementia Toggle Menu What are the Causes and Risk Factors of Alzheimer's and Other Dementias? 10 Early Signs and Symptoms of Alzheimer's and Dementia TrialMatch: Find Clinical Trials for Alzheimer's and Other Dementia Alzheimer's and Dementia Alzheimer's is the most common cause of dementia. Learn more: Common Types of Dementia, What is Alzheimer's? In the case of most progressive dementias, including Alzheimer's disease, there is no cure, but two treatments — donanemab (Kisunla™) and lecanemab (Leqembi®) — demonstrate that removing beta-amyloid, one of the hallmarks of Alzheimer’s disease, from the brain reduces cognitive and functional decline in people living with early Alzheimer’s.
[4] Diagnosis and Management of Dementia: A Review - PMC — Dementia is a common public health problem. 1 Worldwide, approximately 47 million people have dementia and this number is expected to increase to 131 million by 2050. 1 Reductions in age-adjusted incidence of dementia have occurred in the United States (US) and other developed countries over the last 20 years, perhaps associated with increasing
[8] Dementia's Emotional Toll on Families: Coping Strategies — The impact of diminished emotional responses on family relationships can be profound. Imagine telling a funny story to your mother, who always used to laugh at your jokes, only to be met with a blank stare. ... There are strategies for maintaining bonds despite these emotional changes. It's about finding new ways to connect, often through non
[9] Emotional Impact of Dementia on Families: A Caregiver's Guide — Family Impact: Anger can easily spill over into family interactions, causing conflict and hurt feelings. Finding healthy outlets for anger, such as exercise or talking to a therapist, can protect family relationships. Stress. Though rewarding, the demands of caregiving can lead to chronic stress, impacting your physical and emotional well-being
[10] The psychological and emotional impact of dementia — Emotional effects. People with dementia often experience changes in their emotional responses. They may have less control over their feelings and how to express them. For example, someone may overreact to things, have rapid mood changes or feel irritable. They may also appear unusually distant or uninterested in things.
[17] Distinguishing Alzheimer's disease from other major forms of dementia — Although more than 70 known causes of dementia have been recognized, we will limit this article to comparisons between AD, Lewy body dementias (LBD), variants of frontotemporal lobar degeneration and vascular dementia (VaD), as the differential diagnosis of AD and these specific disorders remains a particularly difficult clinical issue.
[19] Similarities and Differences Between Alzheimer's and Dementia — Vascular dementia is the second most common type of dementia, and, unlike Alzheimer's disease, it tends to occur in middle-aged people between the ages of 55 and 70. Of all the cases of dementia, it is estimated that about 10-20 percent of people have vascular dementia, and many remain undiagnosed.
[20] Vascular Dementia vs. Alzheimer's Disease - Healthline — Vascular dementia and Alzheimer's are the two most common types of dementia. While they share some symptoms, they have key differences. They also differ in their causes, treatment approaches
[51] Alzheimer's Disease: Past, Present, and Future - PMC — Although dementia has been described in ancient texts over many centuries (e.g., "Be kind to your father, even if his mind fail him." - Old Testament: Sirach 3:12), our knowledge of its underlying causes is little more than a century old. ... 2005) and large-scale natural history studies (e.g., the Alzheimer's Disease Neuroimaging
[52] History of Dementia - PubMed — In the 19th century, individuals with dementia were recognized as patients, deserving medical care from specialists called alienists, and senile dementia became a medical disease. Subsequently, progresses in neuropathology allowed its fragmentation into different neuropathological conditions.
[54] Evolution in the conceptualization of dementia and Alzheimer's disease ... — Most histories of senile dementia commence with Alois Alzheimer's description in 1906 of the first case of Alzheimer's disease, yet the history of senile dementia before 1906 is quite rich, dating back to the ancient Greek and Roman philosophers and physicians. Over the 2500 years since ancient time …
[56] History of Dementia - ScienceDirect — The history of dementia obviously did not start with the contributions of Alzheimer and his colleagues. ... This chapter will mention some of the early central characters in the field as well as the evolution of the concept of dementia before Alzheimer. ... Philippe Pinel (1745-1826) (Fig. 1.2), did not invent the term dementia (use of the
[57] History of Dementia - PubMed — The term dementia derives from the Latin root demens, which means being out of one's mind. Although the term "dementia" has been used since the 13th century, its mention in the medical community was reported in the 18th century. ... History of Dementia Front Neurol Neurosci. 2019:44:118-126. doi: 10.1159/000494959. Epub 2019 Apr 30. Author
[65] Framing Confusion: Dementia, Society, and History — In 1910, on the basis of this case and a handful more published by Alzheimer and others, Alzheimer's mentor Emil Kraepelin created the category of Alzheimer's disease in the eighth edition of his influential textbook to distinguish early-onset "presenile" cases occurring before age 65 from the much more common senile dementia occurring
[66] The cultural history of dementia - The Lancet Neurology — Bourke also discussed perceptions of dementia in society, particularly relating to gender, race, and age. Dementia was thought to mainly affect White men in the early 20th century, yet we now know that the disease is more prevalent in women than in men and in African American and Hispanic communities than in White populations.
[71] Advancements in Immunity and Dementia Research: Highlights from the ... — In March of 2023, the Alzheimer's Association convened the Alzheimer's Association International Conference (AAIC), Advancements: Immunity, to discuss the roles of the immune system in ADRD. A wide range of topics were discussed, such as animal models that replicate human pathology, immune-related biomarkers and clinical trials, and lessons
[72] Preventing and Treating Alzheimer's Disease and Related Dementias — While NIH did not fund the pivotal phase 3 clinical trials that led to the FDA approvals, NIH funding did enable the essential foundational work for these trials, including research that helped scientists understand the role of amyloid, the protein targeted by these drugs; and develop amyloid PET imaging, a technology central to these trials. To that end, in fall 2023, NIH began funding the Alzheimer’s Disease Tau Platform Clinical Trial, which will test the ability of two tau-targeting therapies to reduce brain tau levels, either alone or in combination with a drug that reduces amyloid protein, in patients with early Alzheimer’s. NIH funds more than 230 active clinical trials testing new drug candidates and lifestyle interventions to prevent or treat Alzheimer’s and related dementias.
[73] A New Approach to Alzheimer's? Study Finds Promising Therapeutic Target — Now, researchers at Yale School of Medicine (YSM) are zeroing in on a byproduct of these plaques, called axonal spheroids, and exploring how to reverse their growth. Previous research at YSM has shown that as these spheroids grow, they block electricity conduction in the axons, which can hinder the ability to communicate with other neurons. In their latest study, this same team, led by Jaime Grutzendler, MD, Dr. Harry Zimmerman and Dr. Nicholas and Viola Spinelli Professor of Neurology and Neuroscience, and Yifei Cai, PhD, associate research scientist in neurology, used a novel approach to reveal the intricate molecular architecture of axonal spheroids. “Our research introduces a new hypothesis that axonal spheroids are a potentially very important pathological process,” says Grutzendler.
[74] 2023—A Bumper Year for the Treatment and Science of Alzheimer's — The year 2023 was a good year for this, as the U.S. FDA approved several drugs, compared to none in 2022. Last July saw the first traditional approval in the U.S. of a disease-modifying therapy for Alzheimer's disease—the anti-amyloid antibody Leqembi, aka lecanemab. Boston's Brigham and Women's Hospital, New York's Columbia University, St
[75] Alzheimer's prevention hope as drug cuts deadly disease onset in half — It's another anti-amyloid treatment, which was approved by the Food and Drug Administration in 2023 to slow the advancement of the disease in those who had already begun to show signs of cognitive
[76] Alzheimer's Impact Movement Advocates Guide — The Alzheimer's Impact Movement (AIM) is the advocacy arm of the Alzheimer's Association. With help from AIM and its members, research funding has more than tripled in five years!
[77] AIM | Alzheimer's Impact Movement — That's why the Alzheimer's Impact Movement (AIM), the Alzheimer's Association and our advocates are unrelenting. We fight to support Alzheimer's and dementia research funding and advance bipartisan legislation that will have a positive and meaningful impact on people living with Alzheimer's and their caregivers today and in the future.
[78] Navigating Awareness and Strategies to Support Dementia Advocacy on ... — Understanding advocacy strategies is essential to improving dementia awareness, reducing stigma, supporting cognitive health promotion, and influencing policy to support people living with dementia. However, there is a dearth of evidence-based research on advocacy strategies used to support dementia awareness.
[80] Raising Awareness for Brain Health: The Importance of Alzheimer's ... — Alzheimer's Awareness Month serves as a crucial time to educate the public on the impact of Alzheimer's disease, a progressive neurodegenerative disorder that affects millions worldwide. The month-long campaign highlights the importance of early diagnosis, advancements in research, and the resources available for patients and caregivers. Given the rising prevalence of Alzheimer's disease
[81] Research Funding | Alzheimer's Association — Today, Alzheimer's and dementia research funding at the National Institutes of Health (NIH) is as much as $3.8 billion annually. As a result of this unprecedented funding, scientists are able to work at a more rapid pace to advance basic disease knowledge, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug
[96] Infographic: Understanding Different Types of Dementia — Infographic: Understanding Different Types of Dementia Read on to learn more about four different types of dementia. [Note: Below is a chart of four columns and five rows that describes what’s happening in the brain, the symptoms, the typical age of diagnosis, diagnosis, and treatment of four types of dementia.] Types of dementia Alzheimer’s Disease, Frontotemporal Dementia, Lewy Body Dementia, and Vascular Dementia Symptoms of frontotemporal dementia Symptoms of Lewy body dementia Symptoms of vascular dementia Frontotemporal dementia: Between 45 and 64 Diagnosis for these four types of dementia Symptoms can be similar among different types of dementia, and some people have more than one form of dementia, which can make an accurate diagnosis difficult. Treatment for these four types of dementia
[98] PDF — Understanding Different Types of Dementia As we age, it’s normal to lose some neurons in the brain. TYPES OF DEMENTIA Alzheimer’s Disease Frontotemporal Dementia Lewy Body Dementia Vascular Dementia What Is Happening in the Brain?* Abnormal deposits of proteins form amyloid plaques and tau tangles throughout the brain. Cognitive Decline • Inability to concentrate, pay attention, or stay alert • Disorganized or illogical ideas Movement Problems • Muscle rigidity • Loss of coordination • Reduced facial expression Sleep Disorders • Insomnia • Excessive daytime sleepiness Visual Hallucinations • Forgetting current or past events • Misplacing items • Trouble following instructions or learning new information • Hallucinations or delusions • Poor judgment Typical Age of Diagnosis Mid 60s and above, with some cases in mid-30s to 60s Between 45 and 64 50 or older Over 65 Diagnosis Symptoms can be similar among different types of dementia, and some people have more than one form of dementia, which can make an accurate diagnosis difficult.
[99] Types of Dementia Explained - WebMD — Dementia and Alzheimer's If you or someone you love gets diagnosed with dementia, it means you or they have a brain condition that causes issues with thinking, behavior, and memory. If you have this type, doctors believe your dementia is caused by another health condition, like a stroke. It's also possible to have short-term dementia-like symptoms due to a health issue, such as a lack of vitamins. While Alzheimer's usually begins with memory problems, vascular dementia can start with trouble planning, organizing, and making decisions. PCA is often due to Alzheimer's disease, but other types of dementia can cause it, too. Alzheimer's Association: "Types of Dementia," "What Is Alzheimer's?" "Wernicke-Korsakoff Syndrome," "Frontotemporal Dementia," "Mixed Dementia Symptoms," "Dementia with Lewy Bodies," "Huntington's Disease," "Sleep Issues and Sundowning."
[100] About Dementia | Alzheimer's Disease and Dementia | CDC — About Dementia | Alzheimer's Disease and Dementia | CDC Alzheimer's Disease and Dementia Alzheimer's Disease and Dementia Menu View All Alzheimer's Disease and Dementia Dementia Basics Signs and Symptoms of Dementia Reducing Risk Healthy People 2030: Dementia and Older Adults View All About Dementia Alzheimer’s disease is the most common type of dementia. Dementia There are many types of dementia. Alzheimer’s disease is the most common type of dementia. Alzheimer's is the most common type of dementia. More than one type of dementia can affect the brain at the same time. For example, a person may have Alzheimer's disease and vascular dementia. Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019. Alzheimer's Disease and Dementia
[141] Diagnosis and Management of Dementia: Review - PubMed — Importance: Worldwide, 47 million people live with dementia and, by 2050, the number is expected to increase to 131 million. Observations: Dementia is an acquired loss of cognition in multiple cognitive domains sufficiently severe to affect social or occupational function. In the United States, Alzheimer disease, one cause of dementia, affects 5.8 million people.
[142] Diagnosis and Management of Dementia: A Review - PMC - PubMed Central (PMC) — In the US, the prevalence of dementia is 15% in people older than 68 years. 3 Dementia is most commonly attributed to Alzheimer's disease (AD), with over five million people currently affected by AD, and 13.8 million are projected to be affected by the year 2050. 4 AD is the 6 th leading cause of death, and the 5 th leading cause among
[143] Diagnosis and Management of Dementia - JAMA Network — Importance Worldwide, 47 million people live with dementia and, by 2050, the number is expected to increase to 131 million.. Observations Dementia is an acquired loss of cognition in multiple cognitive domains sufficiently severe to affect social or occupational function. In the United States, Alzheimer disease, one cause of dementia, affects 5.8 million people.
[145] How Is Alzheimer's Disease Diagnosed? - National Institute on Aging — Doctors use several methods and tools to help determine if a person with thinking or memory problems has Alzheimer's disease. ... blood test results alone should not be used to diagnose dementia but may be taken into consideration along with other tests. However, the availability of these diagnostic tests is still limited. NIA-supported
[151] Machine learning based algorithms for virtual early detection and ... — In 10 studies conducted on dementia, 12 ML algorithms were used: XGBoost classification, Binary logistic regression (LR), A logistic model tree classifier combined with information gain feature selection, 3D convolutional neural networks (3D CNN), k-NearestNeighbor (kNN), support vector machine (SVM), random forest (RF), parallel recurrent convolutional neural network (PRCNN), support vector machine classifiers (SVC), support vector regression (SVR), partial least squares regression (PLSR) and Deep Neural Network (DNN), All of which showing promising results in early detection and screening of the disease. | Bhandari et al.(30) | 2023 | India | This study employed explainable artificial intelligence (XAI) techniques to identify the significant set of gene features contributing to diagnosis and integrated gene expression data from various sources to diagnose Parkinson’s disease (PD) using Machine Learning (ML) based methods.
[153] An Efficient Method for Early Alzheimer's Disease Detection ... - Frontiers — The proposed model achieved a remarkable 99.68% accuracy in distinguishing between the four stages of Alzheimer's: Non-Dementia, Very Mild Dementia, Mild Dementia, and Moderate Dementia. This high accuracy highlights the model's potential for real-time analysis and early diagnosis of AD, offering a promising tool for healthcare professionals.
[154] Early detection of dementia through retinal imaging and trustworthy AI — We propose a novel deep learning framework, Eye-AD, to detect Early-onset Alzheimer’s Disease (EOAD) and Mild Cognitive Impairment (MCI) using OCTA images of retinal microvasculature and choriocapillaris. This study demonstrates strong and consistent associations between the interpretability of Eye-AD and feature analysis of retinal microvasculature and FAZ, indicating that the DVC plays a more important role in EOAD and MCI detection. We proposed a novel deep learning-based model namely Eye-AD, by leveraging OCTA images for the detection of both EOAD and MCI. In conclusion, we have proposed a novel multilevel graph-based deep learning model, Eye-AD, to detect EOAD and MCI through the unique characteristics of OCTA images.
[155] Diagnostic Tools for Alzheimer's Disease: A Narrative Review Based on ... — Dementia has become one of the highest priorities among public health policy issues. ... clinical phenotypes, neuropathology, and pathophysiological mechanisms. This paper provides a narrative review of diagnostic tools for AD, based on our own experience in a prospective study. ... recent advances in structural brain imaging and molecular
[156] Understanding the Diagnostic Process for Dementia — Dementia diagnosis is a complex process that involves thorough evaluations to understand the underlying causes and to determine the most effective management strategies. This article explains the steps and methods used by healthcare professionals to diagnose dementia, highlighting both traditional approaches and advancements in diagnostic
[157] How Doctors Diagnose Dementia: A Detailed Look at the Process — The process of diagnosing dementia is thorough and multifaceted, designed to gather a comprehensive understanding of the individual's health and cognitive status. By integrating both traditional and advanced diagnostic methods, doctors can ensure a more accurate diagnosis, tailor treatments to the individual's needs, and provide the best
[158] The Most Common Misconceptions About Dementia — The Most Common Misconceptions About Dementia. Dementia is one of the most misunderstood conditions affecting older adults. The mere mention of the word can evoke fear, uncertainty, and sadness. ... These misconceptions create unnecessary stigma and prevent individuals from seeking early diagnosis or treatment. Understanding the truth about
[159] Debunking Common Misconceptions About Dementia — Recognizing dementia as a disease, rather than an expected part of aging, is crucial for promoting early diagnosis and intervention. Dementia Does Not Only Affect Memory. One of the most common misconceptions is that dementia solely impacts memory. While memory loss is a defining symptom, dementia affects far more than recollection.
[160] 5 Common Misconceptions About Dementia - Alzheimer's — Here are five of the most common myths and stereotypes followed by the truth, according to the Mayo Clinic: MYTH #1 Memory loss means dementia. People naturally forget from time to time, but dementia is much more than occasional lapses. It's memory issues that are affecting daily functioning. Also, memory loss isn't the first dementia symptom.
[161] Neuropsychological Testing in the Diagnosis of Dementia — Neuropsychological testing can play a major role in the diagnosis of dementia by documenting cognitive deficits, the key criteria for the diagnosis. Because the most common dementia diagnosis, Alzheimer's disease, focuses on memory impairment, tests to assess this domain and to detect and characterize memory deficit are well established with rec-ognized predictive value.
[190] Advances in dementia research and clinical care in 2024 — Progress in dementia research and clinical care has continued to accelerate in 2024. Monoclonal antibody anti-amyloid immunotherapies (AATs) have been approved for clinical use for patients with mild cognitive impairment or early dementia due to Alzheimer's disease in multiple countries and regions, including China, Hong Kong, Israel, Japan, Korea, the EU, the United Arab Emirates, and the USA
[192] Preventing and Treating Alzheimer's Disease and Related Dementias — While NIH did not fund the pivotal phase 3 clinical trials that led to the FDA approvals, NIH funding did enable the essential foundational work for these trials, including research that helped scientists understand the role of amyloid, the protein targeted by these drugs; and develop amyloid PET imaging, a technology central to these trials. To that end, in fall 2023, NIH began funding the Alzheimer’s Disease Tau Platform Clinical Trial, which will test the ability of two tau-targeting therapies to reduce brain tau levels, either alone or in combination with a drug that reduces amyloid protein, in patients with early Alzheimer’s. NIH funds more than 230 active clinical trials testing new drug candidates and lifestyle interventions to prevent or treat Alzheimer’s and related dementias.
[193] New Treatment Reverses Alzheimer's Disease Signs — New Treatment Reverses Alzheimer’s Disease Signs - Penn Medicine Skip to main content Skip to navigation PR News Expand Search Menu Access myPennMedicine Home News Releases New Treatment Reverses Alzheimer’s Disease Signs News Release New Treatment Reverses Alzheimer’s Disease Signs According to a preclinical study from Penn Medicine researchers, a molecular compound mimics the effect of natural chaperones that are depleted in the aging brain December 20, 2023 PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania. In mice that model Alzheimer’s disease, injections of PBA helped to restore signs of normal proteostasis (the protein regulation process) in the animals’ brains while also dramatically improving their performance on a standard memory test, even when administered late in the disease course. Like other neurodegenerative disorders, Alzheimer’s disease features the accumulation of protein aggregates in the brain, and includes the dysfunction of proteostasis, itself. These mice, known as APPNL-G-F mice, accumulate abnormal protein aggregates in their brains, lose many of the synapses that connect their brain cells, and develop severe memory impairment—much like people with Alzheimer’s. The treatment also restored the mice’s ability—which was otherwise abolished—to discriminate between moved and unmoved objects on a standard memory test called the Spatial Object Recognition test.
[209] Monoclonal Antibodies for Alzheimer's Resources - American Academy of ... — Q: What does the Accelerated Approval pathway mean for monoclonal antibody directed against the treatment of Alzheimer's disease therapies? A: As part of the Accelerated Approval pathway, the sponsor is required to conduct a post-market clinical trial to ensure endpoints are met. The sponsor has up to nine years to complete the trial.
[210] Considering challenges for the new Alzheimer's drugs: Clinical ... — Recent approvals of amyloid immunotherapy drugs for early Alzheimer's disease (AD) have been highly controversial. In this piece, we consider challenges from the clinical, population health, and health systems perspectives to the role that the new AD drugs might be expected to play, now and in the future, in alleviating the morbidity caused by AD in the population.
[214] Therapeutic approaches for improving cognitive function in the aging ... — Cognitive stimulation was also associated with improved cognitive function, self-reported quality of life, and communication and social interactions in dementia people (Woods et al., 2012). Although cognition-oriented treatments showed a positive effect on cognitive function, high-quality with larger sample size trials are needed, and further
[215] Cognitive Therapy for Dementia: Options, Research & Activities — Cognitive training was originally developed in the 1970s to treat victims of stroke and head trauma. It proved very successful, and in the 1980s, doctors started using it with individuals suffering from dementia.. This type of therapy — also called brain training, retraining, or remediation — involves practicing a set of standardized tasks. These tasks are designed to improve specific
[216] Cognitive interventions for memory and psychological well-being in ... — The social interaction element of the intervention appears to be a key mechanism driving any changes observed; by encouraging healthy older adults and people living with dementia to engage in a weekly, semi-structured, peer-to-peer group activity, social as well as cognitive function are engaged, leading to a greater likelihood of engagement
[217] Effective Dementia Interventions: Evidence-Based Approaches — Effective Dementia Interventions: Evidence-Based Approaches - NCCDP Facebook Instagram Twitter Linkedin Youtube The most effective dementia interventions focus on symptom management, cognitive stimulation, environmental modifications, and caregiver support. A study published in the Journal of Alzheimer’s Disease found that individuals who participated in regular music therapy sessions had improved behavioral and psychological symptoms of dementia, including reductions in agitation and depression . The mission at NCCDP is to provide world-class training and education on Alzheimer’s disease and related dementias so that every individual living with cognitive change benefits from compassionate, expert care. With recognized certificate programs, ongoing training and a wealth of resources for NCCDP members, NCCDP is your partner for dementia education.
[218] 5 Most Effective Psychosocial Treatments for Dementia — Here Are the 5 Most Effective Psychosocial Treatments for Dementia #1 Validation Therapy. ... Most often, dementia patients keep their negative emotions buried deep inside them. The trapped emotions begin to slowly tear them up inside. ... But, here's the tricky part: when it comes to talking or counseling (psychological) and getting people
[224] Risk factors for dementia - Alzheimer's Society — Learn about the different types of risk factors for dementia, including age, genes, health conditions, lifestyle and sex. Find out how to reduce your risk of dementia with healthy behaviours and support.
[225] Risk factors for dementia - The Lancet — The 2024 update to the standing Lancet Commission on dementia prevention, intervention, and care adds two new risk factors (high LDL cholesterol and vision loss) and indicates that nearly half of all dementia cases worldwide could be prevented or delayed by addressing 14 modifiable risk factors. Read the updated Lancet Commission: Dementia prevention, intervention, and care 2024 in full online.
[226] Dementia Risk Factors - Stanford Health Care — Learn about the factors that increase or decrease the risk of developing dementia, such as age, genetics, smoking, alcohol, cholesterol, and diabetes. Find out how to diagnose and treat dementia and its causes.
[227] Reducing Risk for Dementia | Alzheimer's Disease and Dementia | CDC — Learn how to lower your risk of dementia, including Alzheimer's disease, by adopting healthy lifestyle habits and managing chronic conditions. Find out which factors can increase your risk, such as hearing loss, diabetes, and tobacco use, and how they affect different racial/ethnic groups.
[229] Dementia Prevention: Reduce Your Risk, Starting Now — Dementia Prevention: Reduce Your Risk, Starting Now | Johns Hopkins Medicine Dementia Alzheimer’s disease is the most common, but for up to a third of people with dementia, even some of those diagnosed with Alzheimer’s, vascular disease is a major cause. Vascular dementia results from atherosclerosis plaque buildup and narrowing of the arteries that compromise blood flow to the brain. Vascular disease can cause or worsen dementia. Researchers are exploring the role of vascular disease in the development of Alzheimer’s dementia in particular, but it’s not yet clear if or how this occurs. Since brain changes can start decades before dementia symptoms appear, the earlier you begin preserving your vascular health, the better for your brain. It’s never too soon to address vascular health and potentially prevent dementia. Dementia Dementia Dementia
[231] Mediterranean Diet and Dementia - Is Diet the Path to Prevention? — Given that olive oil is one of the main contributors to the known health impacts of a Mediterranean diet and that olive oil itself has been found to be protective against cognitive decline and dementia, 6,7 this factor alone may explain at least some of the ... Philippou E. Mediterranean diet, cognitive function, and dementia: a systematic
[233] Vitamins and Supplements | Alzheimer's Organization — Omega 3-6-9s are an important type of nutrients required for healthy brain development. They have been shown to have numerous benefits to memory and cognition. Studies have shown that individuals whom consume higher amounts of Omega 3-6-9 show "higher amounts of memory recall and learning" and are 41% less likely to develop dementia.
[234] Genetics of Alzheimer's disease - PMC - PubMed Central (PMC) — Several studies already investigated the importance of genetic markers for the prediction of AD risk. In a recent work an estimate of the risk of developing AD was calculated based on genotype and age. ... a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol. 2004;24(1):1-24. doi
[235] Alzheimer's Disease Genetics Fact Sheet - National Institute on Aging — Researchers have identified several genetic variants that are associated with Alzheimer’s and may increase or decrease a person’s risk of developing the disease. Researchers are also finding other rare genetic variants, in addition to APOE ε2, that appear to provide some protection against developing Alzheimer’s. More research is needed to better understand how certain genetic variants might affect a person’s or group’s risk for Alzheimer’s and to identify treatment and prevention strategies that will work best for that particular group. In addition to the three genetic variants that are known to cause Alzheimer’s, people with Down syndrome have an extra copy of chromosome 21, which carries the APP gene, and a higher risk of developing early-onset Alzheimer’s.
[236] The Genetics of Dementia - PMC — Over 200 different mutations have been identified in these three EOAD genes, and most are fully penetrant (Table 1; consult the Alzheimer Disease and Frontotemporal Dementia Mutation database, http://www.molegen.ua.ac.be/ADMutations, for updated information).12 Disease-causing mutations in these three genes all lead to an increase in extracellular Aβ or a relative overabundance of the Aβ42 species, which is thought to increase Aβ aggregation and amyloid fibril formation.13 The discovery of APP, PSEN1, and PSEN2 contributed to the amyloid hypothesis, which posits that amyloid plays a critical role in AD pathology. Microtubule-associated protein tau (MAPT), located on chromosome 17, is involved in microtubule assembly and maintenance, and has been implicated in FTLD, AD, and other neurologic diseases.28–30 Over 40 mutations have been reported in the gene since its discovery in 1998, mostly in exons 9–13 (Fig. 2).
[237] Advanced Understanding of Dementia Risk Factors, Genetics, and Disease ... — Ten years ago, scientists knew of only 10 genes linked to Alzheimer’s disease; today, we know of more than 70 relevant genetic regions, findings made in large part thanks to NIH funding. NIH scientists have also found two new genes involved in Lewy body dementia, demonstrating how risk genes often overlap across neurodegenerative diseases: One of these genes, BIN1, is also linked to Alzheimer’s disease, while the other, TMEM175, is involved in Parkinson’s disease. Research from the NIA Alzheimer’s Disease Research Centers recently led to the discovery and classification of a new form of dementia called limbic-predominant age-related TDP-43 encephalopathy (LATE). NIH-funded researchers found that Alzheimer’s progression in Down syndrome is similar to other genetic, early onset forms of the disease.
[238] Promising strategies for the prevention of dementia - PubMed — Given that the current pharmaceutical treatment of dementia can only modestly improve symptoms, risk factor modification remains the cornerstone for dementia prevention. Some of the most promising strategies for the prevention of dementia include vascular risk factor control, cognitive activity, physical activity, social engagement, diet, and
[239] Cognitive interventions for memory and psychological well-being in ... — Lifestyle factors that decrease the risk of dementia include moderate physical activity, psychological well-being (e.g., no diagnosis of depression), and regular social engagement (Livingston et al., 2020; Sikkes et al., 2021). A growing body of literature suggests that age-related decline in cognition can sometimes be reduced through interventions of physical activity, social engagement, and mental well-being (Erickson et al., 2011; Gajewski & Falkenstein, 2016; Allen et al., 2020). In recent years, research has pointed to the benefits to both mental health and cognitive performance (e.g., memory, attention) of physical exercise and, separately, of actively engaging in guided use of one’s memory, for example through Reminiscence Therapy (RT).
[242] The relationship between cognitive engagement and better memory in ... — 1 INTRODUCTION. Engagement in cognitively stimulating work and activities is associated with reduced risk of cognitive decline and onset of dementia. 1-3 This suggests that behavioral and lifestyle characteristics or choices may influence age-related change to cognition and provide a potential target for strategies aimed at delaying or preventing dementia. 4, 5 Cognitive engagement across work
[243] Infographic: Making Healthy Lifestyle Choices May Reduce Your Risk of ... — Making healthy lifestyle choices may reduce your risk of dementia. We don't know for certain what, if anything, can prevent dementia, but there may be steps you can take to help reduce your risk. ... Keep physically active; Connect with family and friends; Learn more about these steps and other healthy lifestyle changes you can make to help
[244] Reduce your risk of dementia - Alzheimer's Society — There is a lot of evidence that lifestyle choices can affect our risk of developing dementia. Dementia risk is lowest in people who have healthy behaviours in mid-life (aged 40-65). No single behaviour is guaranteed to prevent dementia, and some are more easy to change than others. Doing regular
[269] Helping Dementia Caregivers | Caregiving | CDC - Centers for Disease ... — Teaches community members and caregivers about the signs and symptoms of dementia, including Alzheimer's disease. Provides information about communication barriers and strategies to overcome them. Offers creative ways to solve problems that caregivers may face. Guides caregivers in managing behavioral and emotional challenges.
[271] Tips for Caregivers and Families of People With Dementia - Alzheimers.gov — Tips for Caregivers and Families of People With Dementia A caregiver, sometimes referred to as a caretaker, refers to anyone who provides care for another person. Millions of people living in the United States take care of a friend or family member with Alzheimer’s disease or a related dementia. For many families, caring for a person with dementia isn’t just one person’s job, but the role of many people who share tasks and responsibilities. These tips and suggestions may help with everyday care and tasks.
[275] Self-Care For Alzheimer's Caregivers - Healthline — Learn how self-care strategies can enhance your well-being and improve the quality of care you provide. ... Dementia caregivers are 1.5 times more likely to face physical difficulties, such as
[276] Alzheimer's Caregiving: Caring for Yourself - National Institute on Aging — Ways to take care of yourself. Taking care of yourself is one of the most important things you can do as a caregiver. This could mean asking family members and friends to help out, making time to do things you enjoy, using adult day care services, or getting help from a local home health care agency.Taking these actions can bring you some relief.
[277] 10 Self-Care Tips for Caregivers - wellnessstrategiesgroup.com — Use free online resources to learn about caregiving strategies. You may learn caregiving tricks you haven't thought of. Attend free webinars that focus on managing caregiver burden. Identifying symptoms of burnout when they begin is critical. 9. Utilize Technology. Connect with other caregivers on social media platforms to gain insights and
[278] Debunking Common Misconceptions About Dementia — Recognizing dementia as a disease, rather than an expected part of aging, is crucial for promoting early diagnosis and intervention. Dementia Does Not Only Affect Memory. One of the most common misconceptions is that dementia solely impacts memory. While memory loss is a defining symptom, dementia affects far more than recollection.
[282] Best Free Dementia Training For Caregivers (Top Materials To Get You ... — Dementia training for caregivers provides essential knowledge and skills to effectively manage the challenges associated with caring for individuals with dementia. By accessing free training resources, caregivers can enhance their understanding of the disease, improve communication strategies, and develop practical caregiving techniques.
[293] What is Dementia Vs. Alzheimers? Differences Explained — Key differences between Alzheimer's, vascular dementia, and Lewy body dementia. Here's a quick comparison to help you understand the key distinctions between Alzheimer's, vascular dementia, and Lewy body dementia: Alzheimer's disease. Gradual memory loss is the hallmark symptom; Linked to brain changes such as amyloid plaques and tau tangles
[313] For Caregivers: Daily Care for People With Dementia — Over time, people with dementia will need more and more help with daily tasks. These include eating meals, taking medicines, and getting enough exercise. They also include personal care needs, such as bathing and dressing. To reduce stress, make these activities part of a routine. Ask family and friends to lend a hand.
[314] Daily routines for dementia caregivers - maintaining quality of life — Establish a Consistent Routine: Stick to a daily schedule to provide stability and predictability for the person with dementia and the caregiver. Include Enjoyable Activities: Incorporate activities that the person with dementia enjoys, such as listening to music, going for walks, or working on puzzles, to maintain their quality of life. Take Care of Yourself: Caregivers must prioritize self
[315] Dementia Checklist For Caregivers: Essential Tips For Quality Care — Whether you're new to caregiving or have been managing dementia care for a while, these tips can offer practical solutions for some of the most common challenges. Creating a Routine for Stability and Comfort. One of the most helpful tools for dementia caregivers is creating a structured daily routine.
[316] Routine & Daily Care Plans - The Center for Brain/Mind Medicine — Routine draws on a different type of memory, one that remains intact longer than short-term memory. Another advantage to a daily routine is that it can reduce anxiety for the primary caregiver as well as for the person with dementia. Creating a more predictable environment and routine helps days go more smoothly.
[317] Practical advice for helping people with dementia with their daily routines — Every person with dementia and every caregiver is unique, and so is their relationship. However, the following general tips may be useful in helping people with dementia remain physically healthy and connected to the world.
[318] Technology and Dementia: The Future is Now - PMC - PubMed Central (PMC) — IoT in dementia research includes early detection through in-home sensors , wearable monitoring and integration of devices for healthcare management . Future Scoping. Future directions in dementia therapy are predicted to include nanotechnology either to "repair" brain damage or for drug delivery .
[319] Future Directions for Dementia Risk Reduction and Prevention Research ... — Drawing on recent integrative reviews and a consensus workshop, the International Research Network on Dementia Prevention developed a consensus statement on priorities for future research. Significant gaps in geographical location, representativeness, diversity, duration, mechanisms, and research on combinations of risk factors were identified.
[320] 2024 NIH Alzheimer's and Related Dementias Research Progress Report ... — 2024 NIH Alzheimer's and Related Dementias Research Progress Report: Advances and Achievements The National Institutes of Health (NIH) drives the nation’s research to better understand the complex and varied causes of Alzheimer’s and related dementias, identify early signs of disease, develop effective interventions to prevent or delay disease progression, and improve care and support for those living with dementia as well as their care partners. Since the 2012 release of the first National Plan, NIH has significantly expanded its investments in Alzheimer’s and related dementias research across the United States and beyond. This report features recent science advances and related efforts in areas including drug development, behavioral and lifestyle interventions, cognitive assessments and biomarkers, dementia risk and protective factors, disease mechanisms, care and caregiving research, career training, and more.
[321] Advances in dementia research and clinical care in 2024 — Progress in dementia research and clinical care has continued to accelerate in 2024. Monoclonal antibody anti-amyloid immunotherapies (AATs) have been approved for clinical use for patients with mild cognitive impairment or early dementia due to Alzheimer's disease in multiple countries and regions, including China, Hong Kong, Israel, Japan, Korea, the EU, the United Arab Emirates, and the USA
[322] The power of a cup of tea: psychosocial interventions in dementia — Dementia is a condition that affects the psychological and emotional wellbeing of not only the person with the diagnosis but also those around them. Therefore, providing holistic support and care to the entire family is essential. Psychosocial interventions have a significant impact on families living with dementia.
[323] Exploring psychosocial interventions for people with dementia that ... — Background Epidemiological predictions suggest that dementia will continue to rise and that this will have social and economic ramifications. Effective interventions, beyond pharmacological management are needed. Psychosocial interventions have largely been investigated in relation to carers of people with dementia, or with regards to their ability to manage dementia symptoms, improve
[325] Psychosocial Interventions for People With Dementia and Their ... — However, psychosocial interventions do not seem to have found their way into routine care yet. We wanted to get an insight into the knowledge and attitudes general practitioners have about occupational and behavioral therapy. ... exploring their experiences with dementia and psychosocial interventions in primary care as well as their
[326] Psychosocial Interventions for People With Dementia and Their ... — Psychosocial interventions, such as occupational and behavioral therapy are effective opportunities to support people with dementia and their caregivers in adapting to the cognitive and behavioral changes and the resulting challenges in everyday life they are facing. ... Barriers for prescriptions of behavioral treatment were a lack of therapy
[328] Nanotechnology and the Future of Dementia Medications — Looking to the future, nanotechnology could revolutionize how we approach dementia treatment. We may see highly targeted therapies that can halt or even reverse the progression of conditions like Alzheimer's disease. ... While we're still in the early days of this nano-revolution in dementia care, the potential is enormous. As our
[332] Tau-targeting nanoparticles for treatment of Alzheimer's disease — The utilization of nanotechnology in the context of targeted therapy for AD exhibits considerable potential and may constitute a paradigm shift in the pursuit of curative interventions. Nevertheless, it is imperative to conduct additional research and clinical trials to ascertain the safety and effectiveness of interventions based on NPs prior
[333] Nanotechnology for the diagnosis and treatment of Alzheimer's disease ... — Fortunately, rapid developments in nanotechnology have provided an unprecedented opportunity to consummate the early detection and treatment of AD .Nanotechnology employs engineered materials or devices on the nano-meter scale to realize diverse functions .The potential medical applications of nanomaterials can be attributed to their comparable size to subcellular structures (such as
[335] Applications and Outcomes of Internet of Things for Patients with ... — The usage of a range of IoT data gathering technologies can assist diagnosis and care for AD/dementia. Meanwhile, combining a range of cameras with various sensors and presence detection technologies such as RFID, NFC, and Bluetooth can be beneficial in increasing the effectiveness of monitoring systems by overcoming the limits of each technology.
[336] A Perspective Roadmap for IoMT-Based Early Detection and Care of the ... — To overcome these, in this section, we propose a dementia care model based on IoT. The proposed model "Demencare" is a set of sensors connected to the IoT network and provides the caretakers and other responsible stakeholders' information about the patient conditions based on the inputs from various sensors (Figure 2).
[337] Applications of artificial intelligence to aid early detection of ... — With the advancement of technology, Artificial Intelligence (AI) shows promising results in assisting with detection of early-stage dementia. This scoping review aims to summarise the current capabilities of AI-aided digital biomarkers to aid in early detection of dementia, and also discusses potential future research directions.
[341] Study finds disparities in diagnosis and treatment of dementia — A new study finds some racial and ethnic groups are less likely to receive an accurate and timely dementia diagnosis or anti-dementia medication compared to non-Hispanic white Americans.
[342] Modeling the Population Equity of Alzheimer Disease Treatments in the US — MeaningThe findings of this study suggest that health system changes that improve access to disease-modifying treatment for AD and reduce diagnosis disparities could contribute to greater improvements in the health equity and population impacts of treatment.
[360] Creating Dementia-Friendly Communities for Social Inclusion: A Scoping ... — Content analysis identified strategies for creating dementia-friendly communities: (a) active involvement of people with dementia and caregivers (b) inclusive environmental design; (c) public education to reduce stigma and raise awareness; and (d) customized strategies informed by theory. Active involvement in the running and organization of dementia-friendly communities by people living with dementia and their informal caregivers was identified as a valued strategy in the development of dementia-friendly communities (Buckner et al., 2019; Dean et al., 2015a, 2015b; Ebert et al., 2020; Heward et al., 2017; Phillipson et al., 2019, p. This scoping review identified four key strategies of creating inclusive dementia-friendly communities that support people with dementia and their informal caregivers: (a) active involvement of people with dementia and their informal caregivers; (b) inclusive environmental design; (c) public education to reduce stigma and raise awareness; and (d) customized strategies informed by dementia-friendly and inclusive theories.
[361] (PDF) Creating dementia friendly community for social inclusion: A ... — Conclusion This scoping review provides an overview of current evidence on strategies that support dementia‐friendly communities for social inclusion.
[363] Cultural Competency in Dementia Care: An African American Case Study — Abstract. The older population in the United States is growing, and within this demographic ethnic and racial diversity is also on the rise. While we know that age is the greatest risk factor for Alzheimer's disease, it must also be known that there is broad diversity in cultural views and interpretations of dementia, which may impact care.